Becton Dickinson (BDX) Cash from Discontinued Operations (2009 - 2025)
Becton Dickinson's (BDX) quarterly Cash from Discontinued Operations came in at 368000000.0 in Q2 2025, down 1050.0% year-on-year from 38736842.11 in Q2 2024, and down 200.0% on a QoQ basis from 368000000.0 in Q1 2025.
Becton Dickinson (BDX) Cash from Discontinued Operations (2009 - 2025) Analysis & Trends
Becton Dickinson (BDX) has 10 years of Cash from Discontinued Operations data on file, last reported at 368000000.0 in Q2 2025.
- On a quarterly basis, Cash from Discontinued Operations fell 1050.0% year-over-year to 368000000.0 in Q2 2025; TTM through Mar 2025 was 336000000.0, a 2340.0% increase from a year earlier, with the FY2024 full-year figure at 46000000.0, down 4500.0% from the prior year.
- Cash from Discontinued Operations for Q2 2025 stood at 368000000.0, down from 368000000.0 in the prior quarter.
- Over the last five years, Cash from Discontinued Operations for BDX reached as high as 368000000.0 in Q1 2025 and fell as low as 368000000.0 in Q2 2025.
- Historically, Cash from Discontinued Operations has averaged 25111111.11 across 5 years, with a median of 1000000.0 in 2023.
- On a YoY basis, Cash from Discontinued Operations climbed as much as 1050.0% in 2025 and fell as far as 1050.0% in 2025.
- Year by year, Cash from Discontinued Operations stood at 144000000.0 in 2021, then tumbled by 193.75% to 135000000.0 in 2022, then jumped by 89.63% to 14000000.0 in 2023, then slumped by 128.57% to 32000000.0 in 2024, then plunged by 1050.0% to 368000000.0 in 2025.
- Per Business Quant data, the three most recent Cash from Discontinued Operations figures were 368000000.0 in Q2 2025, 368000000.0 in Q1 2025, and 32000000.0 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -368.00 Mn |
| Jun 30, 2025 | -368.00 Mn |
| Mar 31, 2025 | 368.00 Mn |
| Mar 31, 2025 | 368.00 Mn |
| Jun 30, 2024 | -32.00 Mn |
| Jun 30, 2024 | -32.00 Mn |
| Dec 31, 2023 | -14.00 Mn |
| Dec 31, 2023 | -14.00 Mn |
| Sep 30, 2023 | -1.00 Mn |
| Sep 30, 2023 | -1.00 Mn |
| Jun 30, 2022 | -135.00 Mn |
| Jun 30, 2022 | -135.00 Mn |
| Mar 31, 2022 | 154.00 Mn |
| Mar 31, 2022 | 154.00 Mn |
| Dec 31, 2021 | 144.00 Mn |
| Dec 31, 2021 | 144.00 Mn |
| Sep 30, 2021 | 110.00 Mn |
| Sep 30, 2021 | 110.00 Mn |
| Sep 30, 2013 | -59.00 Mn |
| Sep 30, 2013 | -59.00 Mn |